financetom
Business
financetom
/
Business
/
Deutsche Bank Gives Its Outlook of Bank of England Policy Action
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Deutsche Bank Gives Its Outlook of Bank of England Policy Action
Oct 22, 2024 12:10 PM

07:38 AM EDT, 10/22/2024 (MT Newswires) -- Deutsche Bank said it now shifted its call to a two-stage rate-cutting cycle at the Bank of England.

In Stage 1, the bank expects the BoE's Monetary Policy Committee to move the Bank Rate sequentially over the next few months, taking the Bank Rate down to 3.75% by May 2025.

Following that, in Stage 2, Deutsche Bank estimates the MPC to move to a quarterly pace of rate cuts all the way down to 3% -- the mid-point of the bank's medium-term neutral rate estimates.

The risk of 50bps rate cuts has risen in recent weeks, but the conditions for 'forceful' rate cuts have yet to be met, and the window for any outsized rate cuts is likely to be small, stated Deutsche Bank.

Importantly, the bank still sees risks skewed to a higher terminal rate -- especially in light of growing expectations of looser fiscal policy in the British Fall Budget -- with the MPC potentially pausing following Stage 1 of the easing cycle, or at 3.75%.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Becton, Dickinson Partners With Quest Diagnostics on Flow Cytometry-Based Companion Diagnostics
Becton, Dickinson Partners With Quest Diagnostics on Flow Cytometry-Based Companion Diagnostics
Jul 25, 2024
01:46 PM EDT, 07/25/2024 (MT Newswires) -- Becton, Dickinson ( BDX ) and Quest Diagnostics ( DGX ) said Thursday they are collaborating to develop, manufacture and commercialize flow cytometry-based companion diagnostics for cancer and other diseases. The companies said they will aim to provide the pharmaceutical industry with joint offerings ranging from exploratory panel development to the manufacturing and...
Vivendi posts H1 growth helped by Lagardère consolidation, Havas
Vivendi posts H1 growth helped by Lagardère consolidation, Havas
Jul 25, 2024
July 25 (Reuters) - French media conglomerate Vivendi reported a 39.3% rise in first-half adjusted operating profit to 619 million euros ($672.30 million) on Thursday, helped notably by consolidation of the publishing group Lagardère and growth in advertising business Havas. WHY IT'S IMPORTANT Vivendi and the Bollore family own a combined 28% stake in the world's biggest music label Universal...
Viking Therapeutics Stock Surges As Company Advances Weight Loss Drug To Late-Stage Trial: What Investors Need To Know
Viking Therapeutics Stock Surges As Company Advances Weight Loss Drug To Late-Stage Trial: What Investors Need To Know
Jul 25, 2024
Viking Therapeutics Inc ( VKTX ) shares are rising Thursday after the biotech company announced plans to advance its experimental weight loss drug to late-stage trials. What Happened: After the market close on Wednesday, Viking Therapeutics ( VKTX ) reported financial results for the second quarter that included an update on VK2735, the lead candidate of the company’s unique series...
US judge should reject Boeing plea deal, crash victim families say
US judge should reject Boeing plea deal, crash victim families say
Jul 25, 2024
July 25 (Reuters) - U.S. District Judge Reed O'Connor should reject a sweetheart plea deal the Justice Department struck with Boeing ( BA ), relatives of some of the 346 people killed in two fatal 737 MAX crashes said on Thursday. Late Wednesday, the planemaker finalized an agreement to plead guilty to a criminal fraud conspiracy charge and pay at...
Copyright 2023-2026 - www.financetom.com All Rights Reserved